You can buy or sell Annexon and other stocks, options, and ETFs commission-free!
Annexon, Inc. Common Stock, also called Annexon, is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in South San Francisco, CA. The listed name for ANNX is Annexon, Inc. Common Stock.
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Mar 31, After Hours